Register for Austin, Texas; OBGYN.net, www.obgyn.net, the premier global women's health resource for Obstetricians, Gynecologists, Reproductive Endocrinologists and their patients announced today its partnership with Ferring Pharmaceuticals, leader in treatment for Pre-Term Labor (PTL) and fertility treatment with its drugs Tractocile and Menopur, the launch of two educational websites, PTLCenter and FerCenter to assist medical professionals and their patients in their online quest for leading edge information and networking. The websites are online now and will be unveiled directly to the physician community in Fort Lauderdale, Florida 24-26th January 2002 at the Ferring Florida “Advances in Infertility Treatment” meeting.
Ronald F. Feinberg, MD, PhD, IVF Medical Director, Reproductive Associates of Delaware and Associate Professor at Yale University, and author of the upcoming book The Syndrome O Phenomenon (The book is in contract, and will be published by Penguin Putnam in 2003), had this to say, "I am excited about the opportunities for education that will result from this collaboration. Ferring has long been a supporter of physician education off line. They have graciously supported educational efforts, both on a local and national level, without major strings attached. It's nice to see them now taking a strong position online. Of course the choice of OBGYN.net to build and manage the websites just makes good sense. OBGYN.net is Ob/Gyn and Reproductive Endocrinology online. It's where all the opinion leaders can be found. I’m looking forward to seeing this project develop. It will be great for the profession!”
The websites will focus on building treatment consensus, peer to peer interactively and webcasts from leading medical congresses. "Unlike most pharmaceutical websites we want to be more than online product brochures, Oblink.com and FerCenter.com are designed to be highly interactive and establish the global platforms for consensus building over vast geographical distances." says Anja Lindner, Interactive Project Manager for Ferring Pharmaceuticals.
Roberta Speyer, President and CEO of OBGYN.net had this to say: "I'm delighted for this opportunity to work with the forward-thinking team at Ferring Pharmaceuticals. We have very ambitious plans for the websites and Ferring has taken the time to really research what the medical professionals want online. They came to us because they know and trust our work. Quality and editorial excellence is Ferring’s goal and we at OBGYN.net know how to deliver on that agenda. This is going to be very good news for the medical community. Fertility issues are highly controversial and PTL treatments are very complex. It is to Ferring's credit that they are ready to take on these two key topics in a truly egalitarian and consensus building fashion. It's a win-win for both the medical professionals and their patients."
For more information please visit:
www.OBLink.com
www.FerCenter.com
www.OBGYN.net
Please direct all Press inquires to:
OBGYN.net
Jennifer Swanson
Jennifer.swanson@obgyn.net
001 (512) 418-2922
Ferring Pharmaceuticals
Sharmi Albrechtsen
Communication Manager
External Communication
Ferring Pharmaceuticals A/S
Direct Phone: +45 28 78 72 09
Fax: +45 28 17 62 09
sharmi.albrechtsen@ferring.com
Veronika Engh
Pressofficer
External Communication (Scandinavia)
Internal Communication
Ferring Pharmaceuticals A/S
International Center
Direct no: +45 28 78 71 99
Fax: +45 28 17 61 99
veronika.engh@ferring.com
